Ferumoxitols

Ferumoxitol is an intravenous iron replacement product used to treat iron deficiency anemia in adult patients with chronic kidney disease. It is a colloidal suspension of iron oxide nanoparticles coated with polyisoxazolyl methoxy polyethylene glycol. Ferumoxitol works by delivering iron directly into the bloodstream, where it can be used by the body to produce hemoglobin, the protein in red blood cells that carries oxygen.

The administration of ferumoxitol is typically done as an infusion. Its efficacy and safety have been evaluated in clinical trials. Common side effects may include nausea, dizziness, headache, and changes in blood pressure. Serious side effects, though less common, can include hypersensitivity reactions.

Ferumoxitol is prescribed when oral iron therapy is ineffective or not tolerated. The dosage and frequency of administration are determined by the patient's individual needs and response. It is important for healthcare professionals to monitor patients closely during and after administration for any adverse reactions. Ferumoxitol is a prescription medication and should only be used under the guidance of a qualified physician.